Wren brings NET Diagnostic Expertise to Pancreatic Cancer Study

Wren brings NET Diagnostic Expertise to Pancreatic Cancer Study

The Wren Laboratories NETest was selected as the diagnostic tool in study of a precision oncology framework for the systematic prioritization of drugs targeting mechanistic tumor dependencies in individual patients.